Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...

Advances in immunohistochemical and molecular technologies have led to the identification of various new renal cell carcinoma (RCC) subtypes since the 2016 WHO classification. Among these, oncocytic ...

A comprehensive exploration of the latest advancements in the pathology of renal tumors. This one-hour webinar will explore the intricacies of renal tumor pathology, focusing on recent developments in ...

Circulating tumor DNA — which is observed via blood test — may be helpful in determining which patients with kidney cancer need more intense treatment and who can have their therapies deescalated.